Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gut microbiota enzymes comprise a broad range of proteins catalyzed by bacteria, archaea, fungi, and phages in the human gastrointestinal tract. These enzymes drive the digestion of otherwise non-digestible compounds, biotransformation of dietary and endogenous molecules, and generation of bioactive metabolites essential to host homeostasis and disease. Enzyme classes include glycoside hydrolases, polysaccharide lyases, bile salt hydrolases, amino acid decarboxylases, and others, which collectively mediate energy harvest, immune modulation, and cross-talk between host and microbiota. The diversity and abundance of these enzyme activities underpin the functional impact of the gut microbiota in health, disease, and drug response, making the collective enzymatic capacity of the gut microbiome an important, though complex, therapeutic target.
Substrate hydrolysis (carbohydrate, protein, lipid breakdown via hydrolases, lyases, etc.) Biotransformation or deconjugation (e.g., bile salt hydrolase and bile acids) Production of bioactive metabolites (SCFAs, indoles, etc.) Modulation of host signaling pathways via metabolite generation
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiota enzyme.